The value of reusing prior nested case-control data in new studies with different outcome

Statistics in Medicine

Volumn 31, Issue 11-12, 2012, Pages 1291-1302

  Salim, Agus ^a   Yang, Qian ^a   Reilly, Marie ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cost effectiveness; Historical data; Population register; Study design; Survival analysis; Weighted estimation

Indexed keywords

ANOREXIA NERVOSA; ARTICLE; BREAST CANCER; CALCULATION; CASE CONTROL STUDY; COMPUTER PROGRAM; EPIDEMIOLOGICAL DATA; FEASIBILITY STUDY; HUMAN; METHODOLOGY; OUTCOME ASSESSMENT; POWER ANALYSIS; PRACTICE GUIDELINE; SIMULATION;

ADULT; ANOREXIA; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MODELS, STATISTICAL; SCHIZOPHRENIA; SOFTWARE; SWEDEN;

EID: 84861186667     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4494     Document Type: Article

References (23)

1. Lee AJ, McMurchy LA, Scott AJ. Re-using data from case-control studies. Statistics in Medicine 1997; 16(12):1377-89.
2. Reilly M, Torrang A, Klint A. Re-use of case-control data for analysis of new outcome variables. Statistics in Medicine 2005; 24:4009-19. DOI: 10.1002/sim.2398.
3. Jiang Y, Scott AJ, Wild CJ. Secondary analysis of case-control data. Statistics in Medicine 2006; 25:1323-1339. DOI: 10.1002/sim.2283.
4. Walter SD. Matched case-control studies with a variable number of controls per case. Applied Statistics 1980; 29:172-179.
5. Salim A, Hultman CM, Sparen P, Reilly M. Combining data from 2 nested case-control studies of overlapping cohorts to improve efficiency. Biostatistics 2009; 10:70-9. DOI: 10.1093/biostatistics/kxn016.
6. Samuelsen SO. A pseudolikelihood approach to analysis of nested case-control studies. Biometrika 1997; 84:379-394. DOI: 10.1093/biomet/84.2.379.
7. Saarela O, Kulathinal S, Arjas E, Laara E. Nested case-control data utilized for multiple outcomes: a likelihood approach and alternatives. Statistics in Medicine 2008; 27:5991-6008. DOI: 10.1002/sim.3416.
8. R: Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2008.
9. Burton PR, Hansell AL, Fortier I, Manolio TA, Khoury MJ, Little J, Elliott P. Size matters: just how big is big?: Quantifying realistic sample size requirements for human genome epidemiology. International Journal of Epidemiology 2009; 38:263-273. DOI: 10.1093/ije/dyn147.
10. Cnattingius S, Hultman CM, Dahl M, Sparen P. Very preterm birth, birth trauma, and the risk of anorexia nervosa among girls. Archives of General Psychiatry 1999; 56:634-8.
11. Hultman CM, Sparen P, Takei N, Murray RM, Cnattingius S. Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case-control study. British Medical Journal 1999; 318:421-6.
12. Gowers S, Bryant -Waugh R. Management of child and adolescent eating disorders: the current evidence base and future directions. The Journal of Child Psychology and Psychiatry 2004; 45:63-83. DOI: 10.1046/j.0021-9630.2003.00309.x.
13. Yadav BS, Sharma SC, Patel FD, Ghoshal S, Kapoor RK. Second primary in the contralateral breast after treatment of breast cancer. Radiotherapy and Oncology 2008; 86(2):171-176. DOI: 10.1016/j.radonc.2007.10.002.
14. Schaapveld M, Visser O, Louwman WJ, Willemse P, de Vries E, van der Graaf W, Otter R, Coebergh J, van Leeuwen F. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Research and Treatment 2008; 110(1):189-197. DOI: 10.1007/s10549-007-9709-2.
15. Hooning MJ, Aleman B, Hauptmann M, Baaijens M, Klijn J, Noyon R, Stovall M, van Leeuwen F. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer. Journal of Clinical Oncology 2008; 26(34):5561-5568. DOI: 10.1200/JCO.2007.16.0192.
16. Silvey SD. Optimal Design. Chapman and Hall: New York, 1980.
17. Lin DY, Zeng D. Proper analysis of secondary phenotype data in case-control association studies. Genetic Epidemiology 2009; 33:256-65. DOI: 10.1002/gepi.20377.
18. Monsees GM, Tamimi RM, Kraft P. Genome-wide association scans for secondary traits using case-control samples. Genetic Epidemiology 2009; 33:717-28. DOI: 10.1002/gepi.20424.
19. Rundle AG, Vineis P, Ahsan H. Design options for molecular epidemiology research within cohort studies. Cancer Epidemiology and Biomarkers Prevention 2005; 14:1899-1907. DOI: 10.1158/1055-9965.EPI-04-0860.
20. Kim S, de Gruttola V. Strategies for cohort sampling under the Cox proportional hazards model, application to an aids clinical trial. Lifetime Data Analysis 1999; 5(2):149-72. DOI: 10.1023/A:1009601512314.
21. Samuelsen SO, Anestad H, Skrondal A. Stratified case-cohort analysis of general cohort sampling designs. Scandinavian Journal of Statistics 2007; 34(1):103-119. DOI: 10.1111/j.1467-9469.2006.00552.x.
22. Borgan O, Samuelsen SO. A review of cohort sampling designs for Cox's regression model: potentials in epidemiology. Norsk Epidemiologi (Norwegian Journal of Epidemiology) 2003; 13:239-248.
23. Karvanen J, Kulathinal S, Gasbarra D. Optimal designs to select individuals for genotyping conditional on observed binary or survival outcomes and non-genetic covariates. Computational Statistics & Data Analysis 2009; 53:1782-1793. DOI: 10.1016/j.csda.2008.02.010.